# Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease

> **NCT00180037** · PHASE3 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 132 (—)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Coenzyme Q10 Nanodispersion (Nanoquinone)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00180037
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 132 (—)
- **Last updated:** 2009-01-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180037, "Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT00180037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*